DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
Clinical trial NCT06504381 · RECRUITING
Trial details
- NCT number
- NCT06504381
- Sponsor
- University of California, San Francisco
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-08
- Primary completion
- 2028-01-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.